Late course accelerated hyperfractionated radiotherapy for clinical T1-2 esophageal carcinoma

Table 1 Pretreatment characteristics

Characteristic	n	%
Age(years)
< 65	30	53.6
≥ 65	26	46.4
Median	59.5
Range	40-74
Gender
Male	41	73.2
Female	15	26.8
T stage
T1	2	3.7
T2	54	96.3
Site
Cervical	2	3.6
Upper-thoracic	19	33.9
Middle-thoracic	34	60.7
Lower-thoracic	1	1.8
Length (cm)
≤ 5	25	44.6
> 5	31	55.4
Median	5.8
Range	2.0-9.0
Thickness of wall (cm)
≤ 1.5	42	75.0
> 1.5	14	25
Median	1.2
Range	0.5-2.7

Table 2 First treatment failures

First failure	n	%
None	31	55.4
Local/regional only	5	8.9
Distant only	14	25.0
Local/regional/distant	2	3.6
Hemorrhage	1	1.8
Complications	2	3.6
Unknown	1	1.8
Total	56	100